Dinglan Zuo Selected Research

Dinglan Zuo Research Topics

13	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2018
6	Neoplasms (Cancer) 04/2024 - 01/2017
5	Neoplasm Metastasis (Metastasis) 10/2023 - 03/2021
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Inflammation (Inflammations) 01/2020
1	Thrombosis (Thrombus) 11/2019
1	Hypoxia (Hypoxemia) 01/2017

2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2021
2	ElafinIBA 03/2022 - 03/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2022 - 03/2021
1	N-methyladenosineIBA 04/2024
1	6-methyladenineIBA 04/2024
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 10/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 10/2022
1	Ubiquitin-Specific ProteasesIBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022
1	Sincalide FDA Link 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2022
1	UbiquitinIBA 01/2022
1	nucleoredoxinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Ethiodized Oil (Ethiodol)FDA Link 11/2019
1	Oxygen (Dioxygen)IBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017